Free Trial

Transcat, Inc. (NASDAQ:TRNS) Shares Acquired by Champlain Investment Partners LLC

Transcat logo with Computer and Technology background

Champlain Investment Partners LLC raised its stake in shares of Transcat, Inc. (NASDAQ:TRNS - Free Report) by 22.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 409,500 shares of the scientific and technical instruments company's stock after buying an additional 74,169 shares during the quarter. Champlain Investment Partners LLC owned about 4.45% of Transcat worth $49,455,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the stock. DekaBank Deutsche Girozentrale acquired a new stake in shares of Transcat during the second quarter worth $40,000. nVerses Capital LLC acquired a new stake in shares of Transcat during the third quarter worth $60,000. First Horizon Advisors Inc. boosted its holdings in shares of Transcat by 26.4% during the second quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company's stock worth $72,000 after purchasing an additional 125 shares during the last quarter. Fifth Third Bancorp boosted its holdings in Transcat by 95.8% in the second quarter. Fifth Third Bancorp now owns 656 shares of the scientific and technical instruments company's stock valued at $79,000 after acquiring an additional 321 shares during the last quarter. Finally, Quest Partners LLC acquired a new position in Transcat in the second quarter valued at $109,000. Institutional investors and hedge funds own 98.34% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on TRNS shares. HC Wainwright reiterated a "buy" rating and issued a $156.00 target price on shares of Transcat in a report on Tuesday, October 29th. StockNews.com cut Transcat from a "hold" rating to a "sell" rating in a report on Tuesday, October 29th. Craig Hallum reduced their target price on Transcat from $138.00 to $113.00 and set a "buy" rating on the stock in a report on Wednesday, October 30th. Oppenheimer reiterated an "outperform" rating and issued a $130.00 target price (down previously from $155.00) on shares of Transcat in a report on Wednesday, October 30th. Finally, Northland Securities reduced their target price on Transcat from $130.00 to $110.00 and set a "market perform" rating on the stock in a report on Wednesday, October 30th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, Transcat presently has an average rating of "Hold" and an average price target of $127.25.

Get Our Latest Stock Analysis on Transcat

Transcat Trading Up 2.1 %

NASDAQ:TRNS traded up $2.23 during mid-day trading on Friday, hitting $109.02. The company had a trading volume of 45,877 shares, compared to its average volume of 105,648. The business has a fifty day simple moving average of $116.61 and a 200-day simple moving average of $121.50. Transcat, Inc. has a 1 year low of $94.29 and a 1 year high of $147.12. The firm has a market capitalization of $1.00 billion, a price-to-earnings ratio of 55.06 and a beta of 0.69.

Transcat (NASDAQ:TRNS - Get Free Report) last announced its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.47 by ($0.12). Transcat had a return on equity of 7.36% and a net margin of 6.63%. The business had revenue of $67.83 million for the quarter, compared to analysts' expectations of $70.30 million. During the same period in the previous year, the firm posted $0.41 earnings per share. The firm's revenue was up 8.0% compared to the same quarter last year. As a group, research analysts anticipate that Transcat, Inc. will post 1.76 earnings per share for the current year.

Transcat Company Profile

(Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

See Also

Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Should you invest $1,000 in Transcat right now?

Before you consider Transcat, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.

While Transcat currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

MicroStrategy Stock: Riding Bitcoin’s Wave to New Highs
How Abacus Life is Transforming Life Insurance into Assets | MarketBeat CEO Series
NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines